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     Mice were irradiated lethally with gamma rays under high dose rate and were treated 
 with preserved homologous bone marrow. The homologous bone marrow was preserved 
 in 15 % glycerol-Tyrode's solution or 10 % dimethyl-sulphoxide TC 199 at —80°C as long 
 as 360 days. 5x106 and 10 x 106 homologous bone marrow cells suspended in 15 % glycerol-
 Tyrode's solution and preserved for 90 and 360 days, respectively, retained their ability 
 to protect lethally irradiated mice from death. 10 x 106 homologous bone marrow cells 
 suspended in 10 % DMSO-TC 199 retained the ability when the period of preservation was 
 less than 270 days. 
                          INTODUCTION 
   Since Lorenz' many workers reported the successful survival of lethally 
irradiated animals treated with hematopoietic tissues. However, Barnes and 
Loutit2) reported a difference between the survivals in the mice treated with 
isologous bone marrow cells and in those treated with homologous bone marrow 
cells. The survival rate in the mice treated with homologous bone marrow 
(HBM) decreased after 21 or 30 days. In 1949, Polge, Smith and Parkes') reported 
a method of freezing and thawing of living cell suspension using as a protective 
medium. And then many workers'-'2) reported that the bone marrow cells 
preserved at low temperature using glycerol as a protective could improve the 
survival of lethally irradiated mice. Also, dimethyl-sulphoxide (DMSO) was as-
certained by many workers13' 14) to protect living cells against freezing injury. 
   The following experiments were undertaken to ascertain that HBM cells 
which were suspended in 15 % glycerol-Tyrode's solution or 10 % DMSO-TC 199 
and preserved at — 80°C as long as 360 days could protect lethally irradiated mice 
and the results were discussed 
                      MATERIALS AND MTGODS 
   Mice. Dd/s and Na2 strain mice supplied exclusively from the Kyoto Uni-
versity Animals Center were used as recipients and donors, respectively. They 
* 'r 1T/0 
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were 8 to 9 week old femal mice weighing 20-25 g at the time of experiments. 
   Bone marrow suspension. Bone marrow obtained from bilateral femurs and 
tibias was suspended in 15 % glycerol-Tyrode's solution4 '2) or 10 % DMSO-TC 199 
solution"--"). A standard technique for this procedure was described"). HBM 
cells were injected via the tail vein of the recipients within 4 to 6 hours after 
irradiation. 
   Freezing and thawing. Slow freezing10,12,21,21-23) means that the temperature 
was lowered at a rate of 1— 2°C/min. from 0°C until —25°C and then cooled to 
— 80°C at a rate not exceeding 10°C/min. The method of slow freezing and fast 
thawing was described in the previous paper1° 
   Cell viability. The eosin-uptake test was performed as a screening test in 
the experiments. The method was described in the previous paper"). 
   Irradiation. A Co" gamma-irradiation facility which belongs to the Institute 
for Chemical Research of Kyoto University was used in the experiments. This 
facility was described in detail by Okamoto and Nakayama24 and Shimizu et al") . 
All recipients were exposed to a single 900 r total body irradiation which resulted 
in LD00/14 days and LD100/21 days. The irradiated mice, after the bone marrow 
transplantation or injection of only Tyrode's solution, were kept in wooden boxes, 
each measuring 15 X21 x 30 cm. Eight to ten mice in a box were fed wheat 
supplemented with dried fish every other day and were given tap water ad 
libitum. 
                            RESULTS 
   1. Some Observations on Treatments with HMI Preserved for Short Periods 
      at 0-4°C (Refrigerator) 
   Experiment 1. This experiment was carried out to protect lethally irradiated 
     Table 1. Survival rate of gamma-irradiated mice treated with preserved HBM. 
                  Percent Number of survival% Survival at days)
Preservation No. of staining Number of irradiated(at days) 
  period experiment with eosin ---                   ( °o) 14 21 30 60 90 120 21 30 60 90 120 
  Control45 — 2/162 0/162 — — — — 0 — — — — 
  Fresh4 10 21/31 18/31 17/30 9/30 6/30 5/30 58 56 30 20 16 
  2 hours2 15 11/14 9/14 4/14 4/14 2/14 1/14 64 28 28 14 7 
  4 hours2 15 10/15 8/15 6/15 3/15 2/15 2/15 53 40 20 13 13 
  2 days3 20 15/21 9/21 7/21 4/21 1/21 1/21 42 33 18 4 4 
  4 days2 26 14/16 8/16 8/16 8/16-8/16 8/16 50 50 50 50 50 
  7 days3 36 13/19 7/19 6/19 6/19 6/19 6/19 36 31 31 31 31 
 14 days2 99 0/15 — 
  The number of nucleated cells injected was 10 million. 
  They were suspended in Tyrode's solution and preserved at 0-4°C for 2 hrs, 4 hrs, 
    2, 4, 7 and 14 days. 
  Control means the group of gamma-irradiated mice treated with only Tyrode's solution 
     or nothing. 
  Fresh means the group of gamma-irradiated treated with fresh homologous bone mar-
      row. 
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      mice with the HBM cells which were suspended in Tyrode's solution and pre-
       served at 0-'4°C (refrigerator) for short periods. The HBM cells were preserved 
       for 2 hours, 4 hours, 4, 7 and 14 days. The survival rates in the experiments 
      were shown in Table 1. Death occurring within 14 days after irradiation was 
      taken as owing to the radiation syndrome or failure of treatment. In these ex-
      periments the number of nucleated cells injected was 10 X 106. In the experiments 
      using fresh HBM, the survival rates were as follows : 67 % at 14 clays, 58 % at 
     21 days, 56 % at 30 days, 30 % at 60 days, 20 % at 90 days and 16 % at 120 days 
      after irradiation. Therefore, 58 % survival rate at 21 days decreased to 16 % at 
      120 days after irradiation. In the experiments with a 2-hour preserved HBM, 
      the survival rates were 64 % at 21 days and 7 % at 120 days. The survival 
      rates in the experiments were 36 to 64 % at 21 days and 7 to 50 % at 120 days 
      after irradiation. However, HBM which was preserved for 14 days did not pro-
      tect the lethally irradiated mice. The survival rates in the mice treated with 
HBM decreased after 21 days. 
         Body weight changes. The body weight changes in the experiments with 
      fresh, a 2-hour preserved HBM and a 2-day preserved HBM are shown in Fig. 1. 
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          Fig. 1. Body weight changes in the miceirradiated lethally and treated with fresh, 
             2-hour and 2-day preserved homologous bone marrow. The number of nucleated 
            cells injected was 10 million. They were suspended in Tyrode's solution. 
              The upper shows the changes in the fresh HBM treatment. The lower left shows 
            the changes in the mice treated with HBM which was preserved for 2 hours at 0-
            4"C. The lower right shows the changes of body weight in the mice treated with 
            HBM which was preserved for 2 days at 0-4°C. 
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Three  types26,271 of body weight changes were observed. a-type : This Type was 
seen in the mice which died between 21 days and 120 days after irradiation. 
Mice showed a rather slight degree of weight loss followed by a tendency to 
increase by the 20th day. Then the body weight started to decrease rapidly or 
gradually and the mice died. b-type : In this type, mice showed a moderate 
degree of weight loss followed by its gradually increase by the 30th day. How-
ever, some mice showed a temporary decrease after 30 days after irradiation. 
Some mice showed body weight changes as if they were treated with isologous 
bone marrow cells. The mice in this type survived for 120 days. c-type : In 
this type, mice showed a rapid and continuous decrease of body weight and died 
between 14 days and 20 days after irradiation. The death occurring after 21 
days was considered as delayed death.Therefore, the mice, which died of 
delayed death, showed a-type in their body weight change. 
   Hematological findings. Leucocyte count. The changes of leucocyte count 
in the peripheral blood are shown in Fig. 2. Leucoycte count in the both con-
trols and treated ones rapidly decreased to 500 to 1000 at 4 days after irradia-
tion. In the controls there was never an increase in leucocyte count until the 
animals died. In the treated mice the leucocyte count began to increse at 5 to 
10 days. Its recovery to the normal level was seen at 10 to 25 days after irr-
adiation. The complete recovery of the peripheral leucocyte count in the mice 
which were treated with 4- and 7-day preserved HBM took place later than in 
the mice treated with HBM preserved for short periods. The leucocyte count in 
the mice treated with 14-day preserved HBM did not recover to the preirradi-
ation level. Reticulocyte count. The changes of reticulocyte count are shown 
in Fig. 3. The reticulocyte count in the controls decreased to zero by 2 days. 
The count in the treated ones decreased to zero by 4 to 5 days followed by its 
increase with reticulocyte crisis. The peak of the crisis appeared at 12 to 22 
days. The recovery of reticulocyte count in the mice transplanted with 2-, 4-
and 7-day preserved HBM appeared later than in the mice transplanted with 
x103 
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  Fig. 2. Leucocyte count in gamma-irradiated mice treated with preserved HBM. The 
    number of nucleated cells injected was 10 million. They were suspended in Tyrode's 
    solution and preserved for 2 hrs, 4 hrs, 2, 4, 7 and 14 days at 0-4°C. Control 
    means the group of gamma-irradiated mice treated with only Tyrode's solution 
    or nothing. Fresh means the group of gamma-irradiated mice treated with fresh 
    HBM. 
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  Fig. 3. Reticulocyte count in gamma-irradiated mice treatedwith preserved HBM. 
    The number of nucleated cells injected was 10 million. They were suspended in 
    Tyrode's solution and preserved for 2 hrs, 4 hrs, 2, 4, 7 and 14 days at 0-4°C. 
    Control means the group of gamma-irradiated mice treated with only Tyrode's 
    solution or nothing. Fresh means the group of gamma-irradiated mice treated with 
    fresh HBM. 
HBM preserved for shorter periods. The mice transplanted with a 14-daypre-
served IIBM showed no recovery. 
   2. Some Observations on Treatment with HBM Preserved for Long Term at 
- 80°C 
   Exp. 1. The experiment was carried out to protect the lethally irradiated 
mice with HBM cells which were preserved at —80°C as long. as 180 days. The 
best method to preserve bone marrow cell suspension was slow freezing and 
fast thawing. The bone marrow cells were suspended in 15 % glycerol-Tyrode's 
solution and stored as long as 180 days. The number of nucleated cells injected 
was 5 million. 
     Table 2.Survival rate of gamma-irradiated mice treated with preserved HBM. 
                   Percent Number of survival°°Survival
 Preservation No.of staining(at days)                       gNumberof irradiated(at days)
  period experiment with eosin --- — (°°) 14 21 30 60 9021 30 60 90 
Control44 — 2/162 0/162 -- — —0 — — — 
  Fresh5 10 27/65 12/65 11/65 6/60 3/60 18 17 10 5 
  30 days2 13 8/16 5/163/16 2/16 2/1631 18 12 12 
  60 days4 17 18/25 11/25 8/25 6/25 5/25 44 32 24 20 
  90 days2 25 6/10 5/10 4/10 2/10 2/10 50 40 20 20 
 120 days2 26 1/13 0/13 — — —0 — — — 
150 days1 33 0/80 — — — 
 180 days  2 51 3/14 0/14 -- — —0 — — — 
  The number of nucleated cells injected was 5 million. 
   They were suspended in 15 % glycerol-Tyrode's solution and preserved at —80°C for 
30 to 180 days. 
   Control means the group of gamma-irradiated mice treated with only Tyrode's solution 
     or nothing. 
   Fresh means the group of gamma-irradiated mice treated with fresh homologous bone 
marrow, 
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   Fig. 4. Changes of percent survival in the mice irradiated lethally and treated with 
     preserved HBM. The number of nucleated cells injected was 5 million. They were 
     suspended in 15% glycerol-Tyrode's solution and preserved for 30 to 180 days at -80°C. 
   Survival rates. The survival rates are shown in Table 2 and Fig. 4. The 
survival rates in the experiment with fresh HBM were as lollows : 41 % at 14 
days, 18 % at 21 days, 17 % at 30 days, 10 % at 60 days, and 5 % at 90 days 
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   Fig. 5. Body weightZchanges in the miceirradiated lethally and transplanted with 
     preserved HBM. The number of nucleated cells injected was 5 million. They were 
     suspended in 15%, glycerol-Tyrode's solution and preserved for 30 to 180 days at -80°C. 
      The upper left shows the changes in the fresh HBM treatment. 
      The lower left shows the changes in the 30-day preserved HBM treatment. 
      The upper right shows the changes in the 60-day preserved HBM treatment. 
      The lower right rhows the changes in the 90-day preserved HBM treatment. 
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after irradiation. As indicated in Table 2, the survival rate was 0 % at 21 days 
in the mice treated with HBM cells which were preserved for 120 days at  —  80°C. 
In the mice treated with 30- to 90-day preserved HBM, the survival rates were 
as follows : 41 to 72 % at 14 days, 18 to 50% at 21 days, 17 to 40 % at 30 days, 
10 to 24 % at 60 days and 5 to 20 % at 90 days after irradiation. The 90-day 
survival rates in the mice treated with 60- and 90-day preserved HBM were better 
than those in other preservation periods. 
   Body weight changes. The body weight changes in the mice treated with 
HBM which was fresh or preserved for 30 to 90 days are shown in Fig. 5. 
Three types described in Part 1 were recognized in this experiment. The c-type 
was recognized in the mice treated with HBM which was preserved for longer 
than 120 days. 
Hematological findings. Leucocyte count. The changes of leucocyte count 
in the peripheral blood are shown in Fig. 6. The leucocyte count in the treated 
ones decreased rapidly to 500 to 1000 at 4 days. In the mice transplanted with 
180-day preserved HBM, there was a temporary increase followed by a rapid 
decrease until they died. In the mice treated otherwise, the leucocyte count 
began to increase at 4 to 10 days. It approached gradually or quickly to the normal 
level and the time of recovery to the normal level was at 21 to 35 days after 
irradiation. The time of recovery to the normal level in the mice treated with 
preserved HBM came later than in those treted with fresh HBM. 
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   Fig. 6. Leucocyte count and reticulocyte count in the mice irradiated lethaIly and 
     treated with preserved HBM. The number of nucleated cells injected was 5 million. 
    They were suspended in 15°o glycerol-Tyrode's solution and preserved for 30, 60, 90 
    and 180 days at -80°C. 
      The right figure shows changes of leucocyte count in the treated mice. 
      The left figure shows changes of reticulocyte count in the treated mice. 
   Reticulocyte count. The changes of reticulocyte count in the peripheral blood 
are shown in Fig. 6. The reticulocyte count in the treated mice decreased to 
zero by 4 to 5 days and incrased at 6 to 10 days. The reticulocyte count in the 
treated with 120- to 180-day preserved HBM showed no increase until the time of 
death. The mice treated with HBM preserved otherwise showed one reticulocyte 
crisis. The peaks of reticulocyte count appeared at 16 to 25 days. The re-
ticulocyte count recovered to the preirradiation level at 25 to 40 days. 
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   Fig. 7. Erythrocyte count and platelet count in the mice irradiated lethally and treat-
    ed with preserved HBM. The number of nucleated cells injected was 5 million. They 
    were suspended in 15% glycerol-Tyrode's solution and preserved for 30, 60, 90 and 180 
    days at —80°C. Fresh means the group of gamma-irradiated mice treated with fresh 
    HBM. 
      The lift figure shows changes of erythrocyte count in the treated mice. 
      The right figure shows changes of platelet count in the treated mice. 
   Erythrocyte count. The changes of erythrocyte count in the peripheral blood 
are shown in Fig. 7. There were no apparent differences between the treated 
ones and the control by the 14 th days. A temporary increase in erythrocyte 
count occurring in the treated mice was considered as a result to dehydration. 
The lowest level of the erythrocyte count occurred at 10 to 14 days. The ery-
throcyte count in the mice treated with 120- to 180-day preserved HBM continued 
to decrease until the time of death after a temporary increase. 
   Platelet count. The changes of platelet count in the peripheral blood are 
shown in Fig. 7. The platelet count in the mice treated with 120- to 180-day 
preserved HBM increased temporarily and then decreased quickly to the level of 
220 X 103 until the time of death. In the transplatation of IIBM preserved for 
different periods, the platelet count decreased to the level of 190 to 200 x103 at 9 to 
10 days and then increased rapidly or gradually to the level of preirradiation at 
18 to 40 days. However, there were some cases which had two decreasing 
phases in the changes in platelet count. The second decreasing phase of the 
platelet count appeared at 10 to 21 days in the mice treated with 30- 60- and 90-
day preserved HBM. 
   Histological findings. The examined tissues were the femoral and sternal 
bone marrow, the thymus, the mesenteric and brachial lymphnode, and the 
spleen. Bone marrow. In the treated mice early regeneration was initiated on 
the 4th to 7th day. In the mice treated with fresh to 90-day preserved HBM, 
the cellularity increased to prevent acute radiation death and recovered to a 
normal cellularity by the 21st day after irradiation. But, in the mice treated 
with 120- to 180-day preserved HBM, the bone marrow stayed hypocellular until 
the time of their death. The time of appearance of early regeneration and 
complete recovery was almost the same as described in the mice treated with 
the isologous bone marrow which was preserved for corresponding periods. 
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       Table 3. The time of appearance of early regeneration and complete recovery in the 
         hematopoietic tissues in gamma-irradiated mice treated with preserved HBM. 
     Preservation Bone marrowSpleenThymus Lymphnode 
     periodredpulp white pulp                  eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
    Fresh4 21 7 21 30 90 9 a 30 90 
    30 days 4 21 9 30 31 w 14 a 21 w 
    60 days 7 21 11 21 24 w 7 a 21 w 
     90 days 4 21 6 21 45 70-90 9 a 21 w 
    150 days 7  — 10 — — — 13 — — — 
       The number of nucleated cells injected was 5 million. 
       They were suspended in 15 % glycerol-Tyrode's solution and preserved at —80°C for 
       30 to 180 days. Fresh means the group of gamma-irradiated mice treated with fresh 
        homologous bone marrow. 
       eg. means early regeneration in the tissues in the mice which were lethally irradiated 
         and treated with fresh and preserved HBM. 
        cp. means complete recovery in the tissues in the mice. 
       "a" means that the examined tissues were atrophic on the 90 th day after irradiation. 
       "w" means that the tissues were wasted on the 90th day after irradiation. 
       Spleen. The red pulp. In the mice treated with fresh to 90-day preserved 
IIBM, early regeneration was discernible on the 5th to 10th day and complete 
   recovery occurred by the 21st day. In the mice treated with 120- to 180-day 
   preserved HBM, the cellularity did not recover to the preirradiation level. 
• The white pulp. In the mice treated with fresh HBM, the white pulp on the 
   14th day consisted of reticular cells and a small number of plasma cells. Early 
    regeneration was seen on the 30 th day and complete recover was seen on the 
   90th day. In the mice treated with 30- to 90-day preserved HBM, early regenera-
   tion was seen by the 90th day. In the mice treated with 120- to 180-day pre-
    served HBM, early regeneration was never seen. 
       Thymus. In the mice treated with fresh HBM, thymocytes in the thymic 
    cortex were seen on the 9th day. However, the thymic medulla stayed wasted 
   on the 14 th day. The cellularity recovered to that of a normal thymus on the 
   90th day, though the thymus still looked small. In the mice treated with 120- to 
   180-day preserved HBM, thymocytes were discernible on the 7th to 13th day. 
    However, the thymus stayed atrophic and complete regeneration was never seen 
   by the time of their death. 
       Lymphnode. In the mice treated with fresh IIBM, the lymphnode on the 
    30th day showed masses of lymphocytes and complete recovery was seen on the 
   90th day. In the mice treated with 120- to 180-day preserved HBM, the lym-
   phnodes were completely wasted or full of plasma cells and reticular cells by 
   the time of their death. The mice treated with HBM showed retarded regenera-
   tion or failure of regeneration in the lymphatic tissues28' as compared with 
    isologous bone marrow treatment. 
       Exp. 2. This experiment was carried out to protect the lethally irradiated 
   mice with 10 x106 nucleated cells of HBM which was preserved up to 360 days. 
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The HBM cells were suspended in 15 % glycerol-Tyrode's solution and were 
frozen slowly, stored and used after fast thawing. 
   Survival rates. The survival rates in the experiment are shown in Table 
4 and Fig. 8. In the mice treated with fresh HBM, the survival rates were as 
follows : 67 % at 14 days, 58 % at 21 days, 56 % at 30 days, 33 % at 60 days, 
20  % at 90 days and 16 % at 120 days after irradiation. In the mice treated 
with 30- to 360-day preserved HBM, the survival rates were as follows : 25 to 
 88  % at 14 days, 0 to 71 % at 21 days, 0 to 40 % at 60 days, 0 to 28 % at 120 
days after irradiation. Except for a 270-day preserved HBM, the survival rates 
     Table 4. Survival rate of gamma-irradiated mice treated with preserved HBM. 
                   Percent Number of survival% Survival 
 Preservation No. of staining Number of irradiated(at days) (at days) 
    period experiment with eosin 
(%) 14 21 30 60 90 120 21 30 60 90 120 
  Control44 —2/162 0/162 — — — — 0 — — — — 
   Fresh5 10 21/31 18/31 17/31 9/31 6/30 5/30 58 56 33 20 16 
   30 days3 13 17/20 7/20 4/20 1/20 1/20 1/20 35 20 5 5 5 
  60 days1 17 6/7 5/7 4/7 2/7 2/7 2/7 71 57 28 28 28 
   90 days2 25 12/14 5/14 4/14 1/14 1/14 1/14 35 28 7 7 7 
  120 days2 26 12/15 9/15 7/15 6/15 4/15 4/15 60 46 40 26 26 
  150 days3 45 9/26 1/26 1/26 1/26 1/26 1/26 3 3 3 3 3 
  180 days2 51 7/14 2/14 2/14 2/14 2/14 2/14 14 14 14 14 14 
 270 days2 56 4/14 0/14 — — — — 0 — — — — 
  360 days2 78 8/16 2/16 1/16 1/16 1/16 1/16 12 6 6 6 6 
   The number of nucleated cells injected was 10 million. 
   They were suspended in 15 °o glycerol-Tyrode's solution and preserved at —80°C for 
    30 to 360 days. 
   Control means the group of gamma-irradiated mice treated with only Tyrode's solu-
    tion or nothing. 
   Fresh means the group of gamma-irradiated mice treated with fresh homologous bone 
      marrow. 
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   Fjg, 8. Changes of percent survival in themice irradiated lethally and treated with 
     preserved I-IBM. The number of nucleated cells injected was 5 million. They were 
     suspended in 15% glycerol-Tyrode's solution and preserved for 30 to 360 days at 
-80°C. 
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were as follows : 33 to 88 % at  14 days, 3 to 71 % at 21 days, 3 to 57 % at 30 
days, 3 to 40 % at 60 days, 3 to 28 % at 90 days and 3 to 28 % at 120 days. 
The best survival rates in the treated mics were obtained by the transplantation 
with 60- and 120-day preserved HBM. 
   Changes of body weight. Three types were seen as described in Part 1. c-
type was not seen in 150-day preserved HBM treatment and only c-type was 
seen in 270-day preserved HBM treatment. The changes were shown in Fig. 9. 
   Hematological findings Leucocyte count. The changes of leucocyte count in 
the peripheral blood are shown in Fig. 10. In the treated mice, the leucocyte 
count in the peripheral blood decreased rapidly to 500-4000 at 3 to 5 days and 
then incresed rapidly or gradually to the level of preirradiation, except in those 
treated with 270-day preserved HBM. The time of recovery to the preirradiation 
level was seen at 12 to 20 days in the mice treated with fresh to 90-day pre- 
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  Fig. 9. Body weight changes in the mice irradiated lethally and treated with preserv-
    ed HBM. The number of nucleated cells injected was 10 million. They were suspend-
     ed in 15% glycerol-Tyrode's solution and preserved at -80°C. 
      The right shows body weight changes in the mice treated with 30 days preserved 
      HBM. 
      The left shows the changes in the mice treated with 60 days preserved HBM. 
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  Fig. 10. Leucocyte count in gamma-irradiated mice treated with preserved }IBM. The 
    number of nucleated cells injected was 10 million. They were suspended in 15% 
    glycerol-Tyrode's solution and preserved for 30 to 360 days at -80'C.
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   Fig. 11. Changes of percentage of neutrophils in gamma-irradiated mice treated with 
     preserved HBM. The number of nucleated cells injected was 10 million. They were 
    suspended in 15% glycerol-Tyrode's solution and preserved for 30 to 360 days at 
-80°C. 
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   Fig. 12. Erythrocyte count in gamma-irradiated mice treated with preserved HBM. 
    The number of nucleated cells injected was 10 million. They were suspended in 15% 
     glycerol-Tyrode's solution and preserved for 30 to 360 days at -80°C.
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   Fig. 13. Reticulocyte count in gamma-irradiated mice treated with preserved HBM. 
    The number of nucleated cells injected was 10 millon. They were suspended in 15% 
    glycerol-Tyrode's solution and preserved for 30 to 360 days at -80°C. 
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served HBM. However, recovery in the mice treated with 120-, 150-, 180-, and 
360-day preserved HBM were seen at 20 to 30 days. 
   The percentage of neutrophils. In the peripheral blood of the mouse dif-
ference between lymphocyte and monocyte can not  be made out clearly, so that 
both lymphocytes and monocytes are described as mononuclear cells"). The 
changes of percentage of neutrophils are shown in Fig. 11. After treatment, 
the percentage increased quickly or gradually to 60 to 90 % from 18 % of preir-
radiation level and recovered to the preirradiation level by the 30th day after 
irradiation. 
   Erythrocyte count. The changes of erythrocyte count in the peripheral blood 
are shown in Fig. 12. After treatment, the erythrocyte count decreased quickly 
or gradually to 3 x106 5.8 x106 at 13 to 18 days and recovered to the preirradia-
tion level at 25 to 30 days. 
   Reticulocyte count. The changes of reticulocyte count in the peripheral 
blood are shown in Fig. 13. After treatment, the reticulocyte count decreased 
to 0.2 % or less at 4 to 5 days and then increased to the peak of crisis at 
10 to 21 days. In the mice treated with a 360-day preserved HBM, two peaks 
of the crisis were seen, one at 11 days and the other at 21 days. These results 
described above were not seen in the mice treated with a 270-day preserved HBM 
x105x 1 OO 
6preservation time6--------- 120 days 
-------- fresh—_—150 days
5--- 30 days 5•--a-- 180 days 
9 0 days,/t 
V i--k— 30 days 49 0                   --r--days4\/~— 3660 days 
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   \,\,\ 
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   Fig. 14. Platelet count in gamma-irradiated mice treated with preserved HBM. The 
    number of nucleatedcells injected was 10 million. 
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   Fig. 15. Hemoglobin content in gamma-irradiatedmice treated with preserved HBM. 
    The number of nucleated cells injected was 10 million. 
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 trea  tment. 
   Platelet count. The changes of platelet count in the peripheral blood are 
shown in Fig. 14. After treatment, platelet count decreased to 100 X103 to 250 x 
103 at 2 to 8 days and then recovered to the level of preirradiation at 16 to 28 
days. 
   Hemoglobin content. Hemoglobin content in the peripheral blood was ex-
amined by the Sahli method. The changes of hemoglobin content in the treated 
mice are shown in Fig. 15. The hemoglobin content decreased to the level of 
78 to 100 % at 10 to 18 days and then increased to the level of preirradiation at 
12 to 30 days. 
   Histological findings. Bone marrow. In the treated mice early regeneration 
occurred between the 4th and 7th day and the time of recovery to a normal 
cellularity was between the 12th and 21st day, except in those treated with a 
270-day preserved HBM. 
   Table 5. The time of appearence of early regeneration and complete recovery in the 
    hematopoietic tissues in gamma-irradiated mice treated with preserved HBM. 
  PreservationBone marrowSpleenThymusLmhnode 
   periodredpulp white pulpyyP              eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
  Fresh4 14 5 21 40 90 — 90 30 90 
  60 days4 16 7 21 — 100 — 90 — 90 
  120 days5 18 6 25 60 100 — 96 — 96 
  150 days5 14 7 20 — 120 — 120 — 100 
  180 days5 20 5 21 — 120 — 120 — 120 
270 days5 — 7 — — —— — — — 
  360 days5 21 8 21 — 100 — 100 — 100 
   The number of nucleated cells injected was 10 million. 
   They were suspended in 15 °o glycerol-Tyrode's solution and preserved at —80°C for 
    30 to 360 days. 
   Fresh means the group of gamma-irradiated mice treated with fresh homologous bone 
      marrow. 
   eg. means early regeneration in the tissues in the mice which were lethally irradiated 
    and treated with fresh and preserved HBM. 
   cp. means complete recovery in the tissues of the mice. 
   Spleen. In the mice treated with fresh to a 360-day preserved HBM, early 
regeneration in the red pulp was discernible on the 6th to 10th day. In the 
treated mice, except in those treated with a 270-day preserved HBM, complete 
recovery in the red pulp occurred between the 12th to 21st day. Also in the 
treated mice, recovery of the white pulp began no earlier than the 40th day. 
Complete recovery of it occurred between the 90th and 120th day. 
   Thymus. After treatment, the thymus stayed atrophic and had a small 
number of thymocytes in the cortex in some experiments. Complete recovery 
in the fresh HBM transplantation was seen on the 41st day. In other experi-
ments, complete recoveries were never seen before the 90th or the 120th day 
after irradiation. 
( 24 )
             Preserved  Hematopoietic Tissues for Treatment of Mice. (II) 
   Lymphnode. The lymphnode stayed wasted and were full of reticular cells 
and plasma cells. Complete recovery was never seen before the 90th to 120th 
day. 
   Exp. 3. This experiment was carried out to protect the lethally irradiated 
mice with HBM cells which were kept at —80°C for 30 to 360 days. The HBM 
cells were suspended in 10 % dimethyl-sulphoxide (DMSO) TC 199 and were 
frozen slowly, stored and used after fast thawing. The number or nucleated 
cells injected was 10 million. 
   Survival rates. The survival rates in the experiment are shown in Table 6 
and Fig. 16. Except in the experiment with fresh and 360-day preserved 
HBM, the survival rates in other experiments were as follows : 44 to 73 % at 
14 days, 5 to 60 % at 21 days, 5 to 33 % at 30 days, 5 to 26 % at 60 days, 5 to 
20 % at 90 days and 5 to 13 % at 120 days. The survival rate in the mice 
treated with a 360-day preserved HBM were as follows : 11% at 14 days, 3% at 
   Table 6. Survival rate of gamma-irradiated mice treated with preserved HBM. 
                  Percent Number of survival% Survival --- t days) 
 Preservation No. of staining Number of irradiated(at days) 
   period experiment with eosin ------- ---_-
                     (,0) 14 21 30 60 90 120 21 30 60 90 120 
  Control 44 — 2/162 0/162 — — — —0 — — — — 
  Freth5 10 21/31 18/31 17/31 9/31 6/30 5/30 58 56 33 20 16 
  30 days2 12 6/14 3/14 1/14 1/14 1/14 1/14 21 7 7 7 7 
  60 days2 12 9/15 2/15 2/15 1/15 1/15 1/15 15 6 6 6 6 
  90 days2 22 7/16 6/16 4/16 1/16 1/16 1/16 37 25 6 6 6 
  120 days 2 37 10/15 9/15 5/15 4/15 3/15 2/15 60 33 26 20 13 
  150 days 2 41 8/18 1/18 1/18 1/18 1/18 1/18 5 5 5 5 5 
  180 days 2 48 11/15 1/15 1/15 1/15 1/15 1/15 6 6 6 6 6 
  270 days 2 50 11/15 6/15 5/15 2/15 2/15 1/15 40 33 13 13 6 
360 days 3 60 3/26 1/26 0/26 —3 0 — — — 
  The number of nucleated cells injected was 10 million. They were suspended in 10 
    DMSO-TC 199 solution and preserved for 30 to 360 days at —80°C.
100. 
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'_. 2 3 4 5 6 9... 12 months 
preservation time 
  Fig. 16. Changes of percent survival in the mice irradiated lethally and treated with 
    preserved HBM. The number of nucleatedcells injected was 10 million. They were 
    suspended in 10°4 DMSO-TC199 solution and preserved for 30 to 360 days at -80°C. 
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  Fig. 17. Body weight changes in the mice irradiated lethally and treated with pre-
    served HBM. The number of nucleated cells injected was 10 millon. They were su-
    spend in 10% DMSO-TC199 solution and preserved at -80°C. The right shows body 
    weight changes in the mice treated with a 90-day preserved HBM. The left shows 
    the changes in the mice treated with a 120-day preserved HBM. 
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    Fig. 18. Leucocyte count in gamma-irradiated mice treated with preserved HBM. 
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  Fig. 19. Changes of percentage of neutrophils in gamma-irradiated mice treated 
    with preserved HBM, 
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21 days and 0 % at 30 days after irradiation. 
   Changes of body weight. Three types consisting of a-, b-, and c-type were 
seen in the treated mice. However, the a-type was not seen in the mice treated 
with a 180-day preserved  HBM and the b-type was not seen in the mice treated 
with a 360-day preserved HBM. The change are shown in Fig. 17. 
   Hematological findings. Leucocyte count. The changes of leucocyte count 
in the peripheral blood are shown in Fig. 18. In the treated mice, leucocyte 
count decreased rapidly to 500 at 3 to 7 days and then increased rapidly or 
gradually to the level of preirradiation. The time of recovery to the preirradia-
tion level was at 13 to 20 days in the mice treated with 30- to 270-day preserved 
HBM, but it was never observed in the mice treated with 360-day preserved 
HBM. 
   The percentage of neutrophils. The changes of percentage of neutrophils 
are shown in Fig. 19. After treatment, the percentage increased quickly or 
gradually to 35 to 100 % from 18 % of preirradiation level and recovered to 
the preirradiation level by the 30th day. 
   Erythrocyte count. Changes of erythrocyte count in the peripheral blood 
are shown in Fig. 20. After treatment, the erythrocyte count decreased quickly 
or gradually to 4.3X10° to 5.7X10° at 14 to 20 days and recovered to the preir-
   (I)(II) 
x106x106 
8 qpreservation time 8  /` ~~--------fresh----------120days 7/ ---30 days7---150 days
NAA111116~~~~60 days~IBOdays 6rN-------- 9 0 days6\ \x---------270 days 40,----360 days55 
44 \ \ 
1020 30 da
ysafter irrad.         Y-l0 20 30             da days after irrad. 
   Fig. 20. Erythrocyte count in gamma-irradiated mice treated with presrved HBM. 
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               60 days  \
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10 2030 days after irrad.10 2030                                                                                                days after irrad. 
   Fig. 21. Reticulocyte count in gamma-irradiated mice treated with preserved HBM. 
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radiation level at 25 to 30 days. However, the recovery in the mice treated 
with a 360-day preserved HBM was never seen. 
   Reticulocyte count. Changes of reticulocyte count in the treated mice were 
shown in Fig. 21. After treatment, the reticulocyte count decreased to 2 to O% 
at 4 to 5 days and then increased to the peak of crisis at 10 to 21 days. In the 
mice treated with a 360-day preserved HBM, the peak was never seen. 
   Platelet count. Changes of platelet count in the treated ones are shown in 
Fig. 22. After treatment, platelet count decreased to 50 X10' to 200 X103 at 7 to 
16 days and then recovered to the preirradiation level at 21 to 30 days after 
irradiation. However, the recovery was never seen in the mice treated with 
a 360-day preserved HBM. 
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x105(II) -                                                 8105 
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     Fig. 22. Platelet count ingamma-irradiated mice treated with preserved HBM. 
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   Fig. 23. Hemoglobin content in gamma-irradiated mice treated with preserved HBM. 
   Hemoglobin content. Changes of hemoglobin content are shown in Fig. 23. 
The hemoglobin content in the treated mice decreased to the level of 70 to 100 
at 10 to 17 days and then increased and reached to the level of preirradiation 
at 12 to 28 days. However, in the mice treated with a 360-day preserved HBM, 
recovery was never seen. 
   Histological findings. The examined tissues were the same as those in the 
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  Table 7. The time of appearance of early regeneration and complete recovery in the 
    hematopoietic tissues in gamma-irradiated mice treated with preserved HBM. 
  Preservation Bone marrow SpleenThymus Lymphnode 
   periodredpulp white pulp              eg. cp. eg. cp. eg. cp. eg. cp. eg. cp. 
  Fresh4 14 5 21 40 90 — 90 30 90 
  60 days 4 14 8 21 — 90 — 90 — 90 
  120 days 5 14 7 21 — 100 — 100 — 100 
  180 days 4 14 7 21 — 120 — 120 — 120 
  270 days 4 15 6 21 — 120 — 120 — 120 
360 days 4 14 7 21 — — — — — 
The number of nucleated cells injected was 10 million. 
  They were suspended in 10 % DMSO-TC 199 solution and preserved at —80`C for 30 
  to 360 days. Fresh means the group of gamma-irradiated mice treated with fresh 
   HBM. 
   eg. means early regeneration in the tissues in the mice which were lethally irradiated 
      and treated with fresh and preserved HBM. 
   cp. means complete recovery in the tissues in the mice. 
experiments described previously. The time of early regeneration and complete 
recovery are shown in Table 7. The times were almost the same as described 
in the treated mice in Exp. 2. 
                          DISCUSSION 
   It is now firmly established that lethally irradiated mice can be protected 
from hematopoietic death by the intravenous injection of isologous or foreign 
hematopoietic tissues' after irradiation. By treating the mice with isologous 
bone marrow, an excellent survival can be obtained. However, when irradiated 
mice are treated with homologous bone marrow, death occurrs starting at 21 to 
30 days after irradiation28-3) . It has been shown that recovery is due to 
recolonization of the host's radiation-damaged hematopoietic tissues by the 
normal cells injected"-"). Therefore, living hematopoietic cells can protect 
lethally irradiated mice from death. The isologous bone marrow which was 
preserved for 270 to 360 days at — 80°C could protect lethally irradiated mice 
from hematopoetic death as well as fresh isologous bone marrow did. Based 
on the results, the homologus bone marrow cells also were preserved for a long 
period. 
   The isologous bone marrow which was preserved at 0—'4°C for less than 3 
days could protect irradiated mice from death. The homologous bone marrow 
was preserved for from 2 hours to 14 day at 0-.'4°C. The number of nucleated 
cells injected was 10 million. The 30-day survival rate in the mice treated 
with HBM which was preserved for less than 4 days were the same as that in 
the mice treated with fresh HBM. The 90-day survival rate better than that 
in the mice treated with fresh HBM was obtained with HBM which was pre-
served for 4 days and 7 days. As indicated in Table 1, delayed death after the 
21st day occurred in the treated ones. As the characteristic findings of the 
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      delayed mortality, the animals were emaciated and showed weight loss and ex-
      tensive depilation and diarrhea occurred in some animals. The characteristic 
      histological findings were retarded recovery or wasting of the lymphatic tissues. 
         To preserve the living cells, the first essential method is to reduce the rate 
     at which physical and chemical phemonena proceed. This is obtained by a low 
      temperature. The formation of ice from water is the most important physical 
      changes occurring when the cells are carried to a low temperature. According 
      to modern cryobiology22,23, the intracellular ice formation is fatal to the cells 
      when they are frozen. To preserve the cells, it is essential to prevent ice for-
      mation inside the cells. When freezing is relatively slow, ice crystals appear to 
      form exclusively in the extracellular space. With increasing rate of cooling, 
     the tendency of extracellular crystal formation dinimishes and ice crystals begin 
      to appear inside the cells. 
         In 1949, Polge and coworkers') reported the first successful freezing of bovine 
      semen using glycerol as a protective medium. And then dimethyl-sulphoxide 
     and polyvinylpyrrolidone were found to protective from freezing injury. The 
      best protective compounds were found among either polyalcohols or monosac-
      charides. To preserve the cells for a long term, the cells must be frozen slowly 
      in the presence of these compounds. Bender'', Tran10', and Ferrebee5' reported 
     that the best volume percent of glycerol was 15 % V/V for the preservation of 
      living cells. Ashwood-Smith"' reported that mouse bone marrow was prevented 
     from injury of freezing with dimethyl-sulphoxide as the protective medium. By 
Ashwood-Smith"' and Richards"' the best volume percent was 10 % V/V. There-
     fore, 15 % glycerol-Tyrode's solution or 10 % DMSO-TC 199 solution was used for 
      the mouse bone marrow preservation. The bone marrow suspension were frozen 
      slowly, stored and used after fast thawing. 
         The HBM was preserved for 30 to 180 days at —80°C. The number of 
     nucleated cells injected was 5 milion. The HBM preseved for more than 120 
     days did not protect the lethally irradiated mice from acute radiation death. 
     The 30-day survival rate in the mice treated with HBM which was preserved 
     for 60 and 90 days was better than that in fresh and 30-day preserved HBM 
      treatment. The 90-day survival rate better than fresh and 30-day preserved 
HBM treatment was obtained with HBM which was preserved for 60 and 90 
     days. The characteristic findings usually found in the delayed death were seen 
     in the mice died. 
         The HBM was suspended in 15 % glycerol-Tyrode's solution and preserved 
     for 30 to 360 days at —80°C. The number of nucleated cells injected was 10 
     million. Generally speaking, the HBM which was preserved for not more than 
     120 days could protect the lethally irradiated mice from acute radiation death as 
     well as the fresh HBM did. However, the-120 day survival rate in the mice 
     transplanted with HBM preserved for longer than 150 days was inferior to 
      that in the experiments using HBM preserved for shorter periods. 
        The I-IBM was suspended in 10 % DMSO-TC 199 solution and preseved for 30 
     to 360 days at —80°C. The number of nucleated cells injected was 10 million. 
     Generally speaking, the preserved HBM did not protect the irradiated mice so 
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well as fresh HBM did. 
   As for the changes of body weight in the mice treated with HBM, three 
types were reported. According to Yamagishils', the three types of weight changes 
are as follows : 1. Mice which showed a rapid and continuous decrease of body 
weight. The mice died between 14 and 20 days. This type was described as the c-
type in the experiment. 2. Mice which showed a moderate degree of weight 
loss followed by its gradual or rapid increase beginning around the 21st day. 
The mice did not die before the 120th day. In some mice showing this type, 
the change of body weight was approximately the same as that in the mice 
treated with the isologous bone marrow. This type was described as the b-type in 
the experiment. 3. Mice which showed a rather slight degree of weight loss 
followed by a tendcncy to increase by the 21st day. Then the body weight 
started to decrease gradually or rapidly and the mice died between 21 and 120 
days. This type was described as the a-type in the experiment. According to 
Makinodan24', three types were recognized in the changes of body weight in the 
mice treated with rat bone marrow. However, c-type in our classification was 
not reported in his three types. A-type in this experiment contained two sub-
types in his types. Only one or two types were seen in some experiments. C-
type was not that of the characteristic delayed death, because irradiated mice 
without treatment died between 14 and 20 days. Typical delayed death was 
recognized as a-type in the experiment. 
   The hematological findings in the peripheral blood returned to the level of 
preirradiation before 30 to 40 days after irradiation. The recovery was recognized 
in the mice suffered from the secondary disease. 
   As for the histological findings in the experiments with HBM, two different 
recovery proceses were seen. The bone marrow and the red pulp of spleen 
showed recovery from conmplete wasting to the level of preirradiation after ir-
radiation before 21 to 28 days. The recovery process was approximately the 
same in the mice treated with isologous bone marrow. After treatment with 
HBM, complete regeneration of the thymus was observed on the 90 th to 120 th 
day. Regeneration of the lymphatic tissues (the lymphnode and the white pulp 
of spleen) was retarded or failed to occur in the mice treated with HBM. The 
time of complete recovery in the lymphatic tissues was shown in Table 5 which 
showed a retarded recovery as compared with isologous bone marrow transplan-
tation. In a number of HBM-transplanted animals with or without secondary 
disease sacrificed for the histological examination on the 21st day, the lym-
phatic tissues consisted of reticular cells, devoid of lymphoid cells, and were 
fully infiltrated with plasma cells. Therefore, it was found that the histologically 
characteristic findings in the mice transplanted with HBM were delayed or in-
complete recovery of the lymphatic tissues. 
   Two theories are proposed on the pathogenesis of the secondary disease and 
delayed death29-3',36-41). 'These theories are based on the assumption that the 
death occurrs as a result of immunological antigen-antibody reaction. The first 
theory is that the host-versus-graft reaction is postulated as the cause of 
death39`4" The other theory is that the secondary disease and delayed death 
                          ( 31 )
                      Masaharu  HAMA 
                Explanations of Plates 
Plate 1. Bone marrow; 4 days after 900r gamma-irradiation and treat-
 ment with fresh HBM. The number of nucleated cells injected was 
 5 million. A group of immature bone marrow cells are seen. 
                                                H-E stain x 400 
Plate 2. Bone Marrow; 15 days after 900r gamma-irradiation and treat-
 ment with 270-day preserved HBM suspended in 15% glycerol-Tyr-
 ode's solution. The cellularity is normal. FI-E stain x100 
Plato 3. Brachial lymphnode; 63 days after 900r gamma-irradiation and 
 treatment with 120-day preserved HBM suspended in 15% glycerol-
 Tyrode's solution. The lymphnode is wasted. H-E stain x400 
Plato 4. White pulp ; 93 days after 900r gamma-irradiation and treat-
 ment with with 120-day preserved HBM suspended in 15% glycerol-
 Tyrode's solution. A marked increase in number of lymphocytes 
 in the white pulp.H-E stain x400 
Plato 5. Brachial lymphnode; 96 days after 900r gamma-irradiation and 
 treatment with 120-day preserved HBM suspended in 10°o DMSO-
 TC199 solution. A little increase in number of lymphocytes in the 
lymphnode.H-E stain x400 
Plato 6. Thymus; 120 days after 900r gamma-irradiation and treatment 
 with 120-day preserved HBM suspended in 10°o DMSO-TC199 solu-
 tion. The thymus stayed atrophic.H-E stain x100 
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     after treatment with HBM areattributed to the graft-versus-host  reaction"-", 
36-38) The factors influencing transplantation immunity are the dose of irradia-
     tion, age of the donor, number of donors cells, and genetic disparity between 
    donor and recipient. Recent evidence has given much support to the graft-
     versus-host reaction. If there exists a graft-versus-host reaction when adult 
    fresh bone marrow is used, what result can be obtained by the use of HBM 
    which was preserved at a low temperature? There are immunologically com-
    petent and incompetent cells in the bone marrow. 
        The effect of storage at 0-4°C. In the author's experiments, the HBM which 
    was prererved for 4 and 7 days at 0-4°C could protect the lethally irradiated 
    mice better than fresh HBM. Therefore, the inactivating effect of storage for 
    4 and 7 days at 0-4°C was found to be more prounounced on immunologically 
    competent cells than on the hemopoietic cells (the immunologically incompetent 
cells) 42) . 
        The effect of storage at -80°03'.  In the author's experiments, when the 
    HBM was preserved for long term at - 80°C with glycerol as a protective addi-
    tive and the number of nucleated cells injected was 5 x 106, the better 90 day 
    survival rate was obtained in the 30-, 60- and 90-day preserved HBM trans-
    plantantion than in the fresh HBM transplantation. The immunologically in-
    competent cells were inactivated when the HBM was preserved for 120 days at 
-80°C. When the HBM was suspended in 15 % glycerol-Tyrode's solution and 
    stored for 360 days at -80°C and the number of nucleated cells injected was 
10X106, delayed death was not prevented. HBM preserved for 120 days or less 
    protected acute radiation death as well as fresh HBM did, but not the HBM 
    preserved for 150 days or more. The 120-day survival rates better than in 
    fresh HBM transplantation, was obtained by 60- and 120-day preserved HBM 
    transplantation. When the HBM was suspended in 10 % DMSO-TC 199 solution 
    and stored for 360 days at -80°C and the number of nucleated cells injected 
    was 10x106, good protective results for acute radiation injury were obtained. 
    However, the 120-day survival rate in the preserved HBM transplatation was 
    inferior to that in the fresh HBM transplantation. 
                                SUMMARY 
       1. The HBM preserved for 7 days or less at 0-4°C protected lethally 
    irradiated mice. The HBM preserved for 4 and 7 days protected the irradiated 
    mice better than fresh did. 
       2. The HBM suspended in 15 % glycerol-Tyrode's solution and stored for 
    120 days or less protected the irradiated mice as well as fresh HBM did. 
       3. The HBM suspended in 10 % DMSO-TC 199 solution and stored for a long 
     period did not protect the lethally irradiated mice so well as freshHBM did. 
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